Skip to main content
CGM Data Analysis 2.0: Functional Data Pattern Recognition and Artificial Intelligence Applications.
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems.
Early Stages of Automated Insulin Delivery.
Metabolic Models, in Silico Trials, and Algorithms.
The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes.
The Promise of Adjunct Medications in Improving Type 1 Diabetes Outcomes: Glucagon-Like Peptide Receptor Agonists.
Expectations and Outcomes From Glucagon-Like Peptide-1 Receptor Agonists As Adjunct Treatment for Type 1 Diabetes - Case Presentations.
Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System.
The Benefits of Using Continuous Glucose Monitoring to Diagnose Type 1 Diabetes.
Discordance Between Clinician and Person-With-Diabetes Perceptions Regarding Technology Barriers and Benefits.